No insider purchase over the last 90 days. The latest was filed 23 Aug 2021.
Central Garden & PET Co, classified in the Food & Agriculture sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Between 18 October 2025 and 18 October 2026, 18 insiders published 49 filings.
The flow runs one way only: 5 sales worth €780k, from 5 insiders, and no purchase. Metz Christopher T filed the largest sale, €266k, on 2 December 2025.
Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (5,810 companies, median 19 filings), a count of 49 filings is above the norm. Our records for Central Garden & PET Co go back to 2016, with 1 purchase and 37 sales on the open market in total. In its latest annual report filed with the SEC (10-K, fiscal year ended 27 September 2025), the company reported revenue of 3.13 bn USD and net income of 162.8 m USD.
For comparison within the same sector, see the insider buying recorded at Village Farms International, Inc. and Orkla ASA. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended September 2025 · cache
25 of 255 declarations
Central Garden & Pet Co (ticker: CENTA) is a U.S.-listed company traded on the NASDAQ market in the United States. Headquartered in Walnut Creek, California, the company is a long-established consumer goods business focused on the pet and garden categories. Its roots go back to its early distribution origins in the garden supply business, and over time it has expanded through a mix of organic growth and acquisitions into a diversified branded-products platform.
The group operates through two core segments: Pet and Garden. In Pet, Central sells a broad assortment of products for dogs, cats, birds, fish, and small animals, including treats, specialty nutrition, grooming and hygiene products, accessories, aquatics products, and animal-health-related items. In Garden, it offers seeds, lawn and garden care, weed and pest control products, tools, outdoor maintenance solutions, and related landscaping and irrigation products. This breadth allows the company to serve mass retail, specialty pet stores, garden centers, home-improvement channels, and select professional customers.
From a competitive standpoint, Central Garden & Pet has meaningful scale within its niches, a portfolio of established brands, and distribution reach across consumer and professional channels. Its competitive edge comes less from a single blockbuster brand and more from category breadth, channel access, and operational execution. Management has recently emphasized a multi-year “Cost and Simplicity” agenda aimed at simplifying operations, improving sourcing and manufacturing efficiency, and supporting margin expansion.
Recent company updates point to improving profitability despite a still-competitive retail environment. In its latest reported fiscal 2026 quarterly results, Central highlighted higher sales, expanded margins, and earnings growth, while reaffirming an outlook for fiscal 2026 non-GAAP diluted EPS of at least $2.70. The company also discussed portfolio optimization, facility closures in the Garden segment, and continued discipline around capital allocation and share repurchases. For French-speaking investors, Central Garden & Pet is best viewed as a U.S. consumer staple-like growth platform with cyclical exposure to home-and-garden spending and pet discretionary demand, underpinned by a sizable branded portfolio and ongoing efficiency initiatives.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Sep 2025 | 3.13 bn USD | 162.8 m USD | 2.55 USD | 10-K |
| Sep 2024 | 3.20 bn USD | 108.0 m USD | 1.62 USD | 10-K |
| Sep 2023 | 3.31 bn USD | 125.6 m USD | 1.88 USD | 10-K |
| Sep 2022 | 3.34 bn USD | 152.2 m USD | 2.24 USD | 10-K |
| Sep 2021 | 3.30 bn USD | 151.7 m USD | 2.75 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.